Parkinson's Drugs Flashcards

1
Q

What is the difference between Parkinson’s disease and Parkinson syndrome?

A

Parkinson’s disease is idiopathic or primary while Parkinson syndrome is induced or secondary.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Which neuronal activity is decreased in Parkinson?

A

Degeneration of dopaminergic neurons in the substantia nigra plus reduced striatal dopamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Why does MPTP causes Parkinsonism?

A

MPTP is metabolized by MAOB and forms the metabolite MPP+ which causes dopaminergic neurons to die.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which drugs can reduce MPTP toxicity?

A

MOA B inhibitors Selegiline and Rasagiline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How is levodopa metabolized?

A

This is a prodrug converted to dopamine by aromatic amino acid decarboxylase (AAAD), also called dopa decarboxylase.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Which transporter does levodopa use to enter CNS?

A

Levodopa enters brain by L-amino acid transporter (but dopamine does not).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Why carbidopa always combine with levodopa?

A

Levodopa when given alone is mostly metabolized in the periphery leading to adverse effects and lack of efficacy due to too little drug entering the brain. Levodopa when combined with carbidopa prevents this peripheral conversion.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the MOA of carbidopa?

A

peripheral dopa decarboxylase inhibitor (aka aromatic amino acid decarboxylase/AAAD inhibitor)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the ADRs of levodopa?

A

Arrhythmias (bc of peripheral conversion dopamine to NE), Hypertension, Psychosis (bc of CNS NE increase). Hypotension (dopamine to D1 receptor –vasodilation) Vomiting (D2 receptor in chemoreceptor trigger zone), Dyskinesia (80% after 10 years’ use), and Response fluctuation (after 10 years use)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the MOA and ADR of bromocriptine?

A

Ergot alkaloid D2 agonist, ADRs: hallucinations in elderly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the MOA and ADR of pramipexole?

A

Non ergot D3 agonist that reduces free radical damage (scavenges H2O2), ADR: hallucinations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the MOA and ADR of Ropinirole and Selegiline?

A

MAO B inhibitors, ADRs: may enhance adverse effects of L-dopa, Dyskinesia, psychosis, insomnia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the MOA of tolcapone and entacapone?

A

inhibit COMT and enhance levodopa uptake and efficacy. In a normal adult, COMT (Catechol-O-Methyltransferase) breaks down L-dopa to 3-O-methyldopa, a less effective metabolite.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Of tolcapone and entacapone, which one is toxic?

A

Tolcapone because it is hepatotoxic and has both peripheral and central action. Entacapone has only peripheral action and has not such major toxicity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Why does vitamin B6 increases peripheral metabolism of levodopa?

A

Vitamin B6 is a cofactor for dopa decarboxylase so it increases peripheral metabolism of levodopa thereby decreasing its effectiveness.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Explain the ADR response fluctuation of levodopa.

A

Response to levodopa is reduced after several years’ use. Wearing off: drug concentration is low between doses. On-off phenomenon: unrelated to the timing of doses.

17
Q

What is the MOA and ADR of pergolide?

A

Ergot alkaloid D2 agonist withdrawn from U.S. because of increased rates of valvular heart disease.

18
Q

Which receptors ergots act on and how?

A

Partial agonist of serotonin 2A receptor